Climb Bio (CLYM) Other Non Operating Income (2020 - 2026)
Climb Bio (CLYM) reported Other Non Operating Income of -$25000.0 for Q1 2026, up 50.0% on a YoY basis from -$16666.7 in Q1 2025, and up 45.65% quarter-over-quarter from -$46000.0 in Q4 2025.
Climb Bio (CLYM) Other Non Operating Income (2020 - 2026) Analysis & Trends
Climb Bio has reported Other Non Operating Income for 7 years, with the latest figure at -$25000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 50.0% year-over-year to -$25000.0; the trailing twelve-month figure through Mar 2026 stood at -$266000.0 (down 103.28% YoY), and the FY2025 full-year result was -$291000.0, down 103.58% from the prior year.
- Other Non Operating Income for Q1 2026 stood at -$25000.0, up from -$46000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $8.1 million in Q4 2024, with the low at -$934000.0 in Q3 2022.
- Historically, Other Non Operating Income has averaged $830000.0 across 5 years, with a median of -$2000.0 in 2024.
- Annual changes were most pronounced in 2022 — Other Non Operating Income surged 1034.18% — and 2025, when it tumbled 8000.0%.
- Climb Bio's Other Non Operating Income stood at $1.8 million in 2022, then declined by 17.35% to $1.5 million in 2023, then jumped by 447.33% to $8.1 million in 2024, then tumbled by 100.57% to -$46000.0 in 2025, then surged by 45.65% to -$25000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$25000.0 (Q1 2026), -$46000.0 (Q4 2025), and -$33000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Climb Bio | 740.73 Mn | 740.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25,000.00 |
| Dec 31, 2025 | -46,000.00 |
| Sep 30, 2025 | -33,000.00 |
| Jun 30, 2025 | -162,000.00 |
| Mar 31, 2025 | -50,000.00 |
| Dec 31, 2024 | 8.11 Mn |
| Sep 30, 2024 | 52,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | 1.31 Mn |
| Dec 31, 2023 | 1.48 Mn |
| Sep 30, 2023 | 1.03 Mn |
| Jun 30, 2023 | 1.49 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 1.79 Mn |
| Sep 30, 2022 | -934,000.00 |
| Jun 30, 2022 | -895,000.00 |
| Mar 31, 2022 | -157,000.00 |
| Dec 31, 2021 | 158,000.00 |
| Sep 30, 2021 | -232,000.00 |
| Jun 30, 2021 | -12,000.00 |